Ekso Bionics Holdings (STU:23E2) Days Sales Outstanding : 138.45 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Ekso Bionics Holdings Days Sales Outstanding?

Ekso Bionics Holdings's average Accounts Receivable for the three months ended in Mar. 2024 was €5.24 Mil. Ekso Bionics Holdings's Revenue for the three months ended in Mar. 2024 was €3.46 Mil. Hence, Ekso Bionics Holdings's Days Sales Outstanding for the three months ended in Mar. 2024 was 138.45.

The historical rank and industry rank for Ekso Bionics Holdings's Days Sales Outstanding or its related term are showing as below:

STU:23E2' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.39 Med: 109.41 Max: 173.25
Current: 110.72

During the past 12 years, Ekso Bionics Holdings's highest Days Sales Outstanding was 173.25. The lowest was 49.39. And the median was 109.41.

STU:23E2's Days Sales Outstanding is ranked worse than
81.71% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: 65.41 vs STU:23E2: 110.72

Ekso Bionics Holdings's Days Sales Outstanding increased from Mar. 2023 (105.16) to Mar. 2024 (138.45).

Ekso Bionics Holdings Days Sales Outstanding Historical Data

The historical data trend for Ekso Bionics Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Days Sales Outstanding Chart

Ekso Bionics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

115.17

183.40

124.25

127.15

103.89

Ekso Bionics Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															105.16	96.39	107.44	109.61	138.45

Competitive Comparison of Ekso Bionics Holdings's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ekso Bionics Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Days Sales Outstanding falls into.

Ekso Bionics Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ekso Bionics Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4.366	+	5.176)	/	2 )	/	16.762	*	365
=	4.771					/	16.762	*	365
=	103.89

Ekso Bionics Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (5.176	+	5.311)	/	2 )	/	3.456	*	365 / 4
=	5.2435					/	3.456	*	365 / 4
=	138.45

Ekso Bionics Holdings (STU:23E2) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Ekso Bionics Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Ekso Bionics Holdings (STU:23E2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (STU:23E2) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

EKSO:USA

Address

101 Glacier Point, Suite A, San Rafael, CA, USA, 94901

Website

https://www.eksobionics.com

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings (STU:23E2) Headlines

No Headlines